On its popular Today Show program, NBC News announced this morning that it has uncovered internal documents from drug manufacturer Johnson & Johnson that prove the company knew the Ortho Evra birth control patch was dangerous. According to the documents, NBC reports that Johnson & Johnson knew the Ortho Evra patch was 12 times more likely to cause strokes and 18 times more likely to cause blood clots than traditional birth control pills.
The FDA approved a label change to Johnson & Johnson's Ortho Evra birth control patch on January 18, 2008.
Two Canadian women have died and numerous others have suffered blood clots, heart attacks and other medical problems in the span of about four years after using the well-known but increasingly controversial Evra birth-control patch.
In a 5-2 decision, the Ohio Supreme Court Thursday morning upheld the constitutionality of a 2004 law capping damages for pain, suffering, and other non-economic claims in personal injury and other lawsuits.
Ortho Evra Birth Control Patch studies that proved the contraceptive patch exposed women to dangerously high levels of estrogen where either altered or withheld by Johnson & Johnson before the medication was approved by the FDA.
Ortho Evra manufacturer, Johnson & Johnson, recently settled a lawsuit with the family of a 14-year-old girl killed by the defective birth control patch. The case is just one of many Ortho Evra lawsuits settled by Johnson & Johnson prior to going trial.
Johnson & Johnson agreed to pay $1.25 million to settle a lawsuit over the death of a 14-year-old girl who used the company's Ortho Evra birth-control patch, according to court records.
The numbers keep adding up for the Ortho Evra birth-control patch. Not sales those are down sharply but the docket of product liability cases filed against Johnson & Johnson.
Facing a rising tide of lawsuits over its Ortho Evra birth-control patch, Johnson & Johnson has always maintained that the patch is a "safe and needed" form of contraception.
Johnson & Johnson improperly claimed its Ortho Evra birth-control patch posed a low safety risk to women, a product-safety executive told Chief Executive Officer William Weldon in a 2005 letter, court records show.
